Coordinate expression of the vesicular acetylcholine transporter and choline acetyltransferase following septohippocampal pathway lesions

Journal of Neurochemistry

Volumn 71, Issue 6, 1998, Pages 2411-2420

  Gilmor, Michelle L ^a   Counts, Scott E ^a   Wiley, Ronald G ^b   Levey, Allan I ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Antibodies; Choline acetyltransferase; Cholinergic lesion; Hippocampus; Medial septum; Vesicular acetylcholine transporter

Indexed keywords

CHOLINE ACETYLTRANSFERASE; VESICULAR ACETYLCHOLINE TRANSPORTER;

ANIMAL TISSUE; ARTICLE; CELL COUNT; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; INTRON; MALE; MOLECULAR CLONING; NERVE FIBER TRANSECTION; NONHUMAN; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; TISSUE DISTRIBUTION;

EID: 0031772148     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71062411.x     Document Type: Article

References (49)

1. 3H] Vesamicol binding in brain: autoradiographic distribution, pharmacology, and effects of cholinergic lesions. Synapse 2, 486-493.
2. Armstrong D., Terry R., Deteresa R., Bruce G., Hersh L., and Gage F. (1987) Response of septal cholinergic neurons to axotomy. J. Comp. Neurol. 264, 421-436.
3. Arvidsson U., Riedl M., Elde R., and Meister B. (1997) Vesicular acetylcholine transporter (VAChT) protein: a novel and unique marker for cholinergic neurons in the central and peripheral nervous systems. J. Comp. Neurol. 378, 454-467.
4. Berrard S., Varoqui H., Cervini R., Isräel M., Mallet J., and Diebler M.-F. (1995) Coregulation of two embedded gene products, choline acetyltransferase and the vesicular acetylcholine transporter. J. Neurochem. 65, 939-942.
5. Berse B. and Blusztajn J. K. (1995) Coordinated up-regulation of choline acetyltransferase and vesicular acetylcholine transporter gene expression by the retinoic acid receptor alpha, cAMP, and leukemia inhibitory factor/ciliary neurotrophic factor signaling pathways in a murine septal cell line. J. Biol. Chem. 270, 22101-22104.
6. Book A. A., Wiley R. G., and Schweitzer J. B. (1992) Specificity of 192 IgG-saporin for NGF receptor-positive cholinergic basal forebrain neurons in the rat. Brain Res. 590, 350-355.
7. Book A. A., Wiley R. G., and Schweitzer J. B. (1994) 192 IgG-saporin: I. Specific lethality for cholinergic neurons in the basal forebrain of the rat. J. Neuropathol. Exp. Neurol. 53, 95-102.
8. Cervini R., Houhou L., Pradat P.-F., Bejanin S., Mallet J., and Berrard S. (1995) Specific vesicular acetylcholine transporter promoters lie within the first intron of the rat choline acetyltransferase gene. J. Biol. Chem. 270, 24654-24657.
9. Coyle J. R., Price D. L., and DeLong M. R. (1983) Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219, 1184-1190.
10. Efange S. M. N., Garland E. M., Staley J. K., Khare A. B., and Mash D. C. (1997) Vesicular acetylcholine transporter density and Alzheimer's disease. Neurobiol. Aging 18, 407-413.
11. Eiden L. E. (1998) The cholinergic gene locus. J. Neurochem. 70, 2227-2240.
12. Erickson J. D., Varoqui H., Schäfer M. K.-H., Modi W., Diebler M.-F., Weihe E., Rand J., Eiden L. E., Bonner T. I., and Usdin T. B. (1994) Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus. J. Biol. Chem. 269, 21929-21932.
13. Fonnum F. (1975) A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 24, 407-409.
14. Gage F. H., Wictorin K., Fischer W., Williams L. R., Varon S., and Bjorklund A. (1986) Retrograde cell changes in medial septum and diagonal band following fimbria-fornix transection: quantitative temporal analysis. Neuroscience 19, 241-255.
15. Gilmor M. L., Nash N. R., Roghani A., Edwards R. H., Yi H., Hersch S. M., and Levey A. I. (1996) Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. J. Neurosci. 16, 2179-2190.
16. Haigh J. R., Noremberg K., and Parsons S. M. (1994) Acetylcholine active transport by rat brain synaptic vesicles. Neuroreport 5, 773-776.
17. Heckers S., Ohtake T., Wiley R. G., Lappi D. A., Geula C., and Mesulam M.-M. (1994) Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor. J. Neurosci. 14, 1271-1289.
18. Hefti F., Hartikka J., Salvatierra A., Weiner W. J., and Mash D. C. (1986) Localization of nerve growth factor receptors in cholinergic neurons of the human basal forebrain. Neurosci. Lett. 69, 37-41.
19. Hicks B. W., Rogers G. A., and Parsons S. M. (1991) Purification and characterization of a nonvesicular vesamicol-binding protein from electric organ and demonstration of a related protein in mammalian brain. J. Neurochem. 57, 509-519.
20. Holler T., Berse B., Cermak J. M., Diebler M.-F., and Blusztajn J. K. (1996) Differences in the developmental expression of the vesicular acetylcholine transporter and choline acetyltransferase in the rat brain. Neurosci. Lett. 212, 107-110.
21. Holtzman D. M., Li Y., Parada L. F., Kinsman S., Chen C., Valletta J. S., Zho J., Long J. B., and Mobley W. C. (1992) p140 trk mRNA marks NGF-responsive forebrain neurons: evidence that trk gene expression is induced by NGF. Neuron 9, 465-478.
22. Ichikawa T., Ajiki K., Matsuura J., and Misawa H. (1997) Localization of two cholinergic markers, choline acetyltransferase and vesicular acetylcholine transporter, in the central nervous system of the rat: in situ hybridization histochemistry and immunohistochemistry. J. Chem. Neuroanat. 13, 23-39.
23. 3H]Vesamicol binding in human brain cholinergic deficiency disorders. Neurosci. Lett. 117, 347-352.
24. Kuhl D. E., Minoshima S., Fessler J. A., Frey K. A., Foster N. L., Ficaro E. P., Wieland D. M., and Koeppe R. A. (1996) In vivo mapping of cholinergic terminals in normal aging. Alzheimer's disease, and Parkinson's disease. Ann. Neurol. 40, 399-410.
25. Leanza G., Nilsson O. G., Wiley R. G., and Bjorklund A. (1995) Selective lesioning of the basal forebrain cholinergic system by intraventricular 192 IgG-saporin: behavioural, biochemical and stereological studies in the rat. Eur. J. Neurosci. 7, 329-343.
26. Levey A. I., Rye D. B., and Wainer B. H. (1982) Immunochemical studies of bovine and human choline-O-acetyltransferase using monoclonal antibodies. J. Neurochem. 39, 1652-1659.
27. Levey A. I., Armstrong D. M., Atweh S. F., Terry R. D., and Wainer B. H. (1983a) Monoclonal antibodies to choline acetyltransferase: production, specificity, and immunohistochemistry. J. Neurosci. 3, 1-9.
28. Levey A. I., Wainer B., Mufson E. J., and Mesulam M.-M. (1983b) Co-localization of acetylcholinesterase and choline acetyltransferase in the rat cerebrum. Neuroscience 9, 9-22.
29. Levey A. I., Edmunds S. M., Koliatsos V., Wiley R. G., and Heilman C. J. (1995) Expression of m1-m4 muscarinic acetylcholine receptor proteins in hippocampus and regulation by cholinergic innervation. J. Neurosci. 15, 4077-4092.
30. Marien M. R., Parsons S. M., and Altar C. A. (1987) Quantitative autoradiography of brain binding sites for the vesicular acetylcholine transport blocker 2-(4-phenylpiperidino)cyclohexanol (AH5183). Proc. Natl. Acad. Sci. USA 84, 876-880.
31. Misawa H., Takahashi R., and Deguchi T. (1995) Coordinate expression of vesicular acetylcholine transporter and choline acetyltransferase in sympathetic superior cervical neurones. Neuroreport 6, 965-968.
32. Naumann T., Peterson G. M., and Frotscher M. (1992) Fine structure of rat septohippocampal neurons: II. A time course analysis following axotomy. J. Comp. Neurol. 325, 219-242.
33. Naumann T., Kermer P., and Frotscher M. (1994) Fine structure of rat septohippocampal neurons. III. Recovery of choline acetyltransferase immunoreactivity after fimbria-fornix transection. J. Comp. Neurol. 350, 161-170.
34. Peterson G. M., Naumann T., and Frotscher M. (1992) Identified septohippocampal neurons survive axotomy: a fine-structural analysis in the rat. Neurosci. Lett. 138, 81-85.
35. Prince H. K., Conn P. J., Blackstone C. D., Huganir R. L., and Levey A. I. (1995) Down-regulation of AMPA receptor subunit GluR2 in amygdaloid kindling. J. Neurochem. 64, 462-465.
36. Roghani A., Shirzadi A., Butcher L. L., and Edwards R. H. (1998) Distribution of the vesicular transporter for acetylcholine in the rat central nervous system. Neuroscience 82, 1195-1212.
37. 3H] vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions. Neuroscience 35, 327-333.
38. Schafer M. K.-H., Eiden L. E., and Weihe E. (1998) Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter. I. Central nervous system. Neuroscience 84, 331-359.
39. Slotkin T. A., Seidler F. J., Crain B. J., Bell J. M., Bissette G., and Nemeroff C. B. (1990) Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy. Proc. Natl. Acad. Sci. USA 87, 2452-2455.
40. Slotkin T. A., Nemeroff C. B., Bissette G., and Seidler F. J. (1994) Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. J. Clin. Invest. 94, 696-702.
41. Song H., Ming G., Fon E., Bellocchio E., Edwards R. H., and Poo M. (1997) Expression of a putative vesicular acetylcholine transporter facilitates quantal transmitter packaging. Neuron 18, 815-826.
42. Tanaka H., Zhao Y., Wu D., and Hersh L. B. (1998) The use of DNase I hypersensitivity site mapping to identify regulatory regions of the human cholinergic gene locus. J. Neurochem. 70, 1799-1808.
43. Varoqui H. and Erickson J. D. (1996) Active transport of acetylcholine by the human vesicular acetylcholine transporter. J. Biol. Chem. 271, 27229-27232.
44. Waite J. J., Wardlow M. L., Chen A. C., Lappi D. A., Wiley R. G., and Thai L. J. (1994) Time course of cholinergic and monoaminergic changes in rat brain after immunolesioning with 192 IgG-saporin. Neurosci. Lett. 169, 154-158.
45. Weihe E., Tao-Cheng J.-H., Schäfer M. K.-H., Erickson J. D., and Eiden L. E. (1996) Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles. Proc. Natl. Acad. Sci. USA 93, 3547-3552.
46. Whitehouse P. J., Price D. L., Struble R. G., Clark A. W., Coyle J. T., and Delong M. R. (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215, 1237-1239.
47. Wiley R. G. (1992) Neural lesioning with ribosome-inactivating proteins: suicide transport and immunolesioning. Trends Neurosci. 15, 285-290.
48. Wiley R. G. and Lappi D. A. (1993) Preparation of anti-neuronal immunotoxins for selective neural immunolesioning. Neurosci. Protocols 20, 1-11.
49. Wiley R. G., Oeltmann T. N., and Lappi D. A. (1991) Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor. Brain Res. 562, 149-153.